Ca2+/CaN/NFAT signaling is an important pathway in the T-cell activation of SLE and some calcineurin inhibitors such as cyclosporine A and tacrolimus have been used in the clinical treatment of SLE [40]. This evidence concerns the gene NUP214 and systemic lupus erythematosus.